Related Experiment Video

Updated: Aug 7, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

Neurometabolic diseases in the newborn

James J Filiano1

  • 1Department of Pediatric Medicine, Dartmouth Medical School Children's Hospital at Dartmouth Hitchcock Medical Center, Lebanon, NH 03756-0001, USA. james.j.filiano@hitchcock.org

Clinics in Perinatology
|June 13, 2006
PubMed

Insights

This guide introduces neurometabolic diseases in newborns for primary care providers. It covers recognition, diagnosis, and collaboration with specialists for better infant care.

Area of Science:

  • Neonatal Medicine
  • Genetics
  • Neurology

Background:

  • Neurometabolic diseases are a group of genetic disorders affecting newborns.
  • These conditions include inborn errors of metabolism, neural topography disorders, and degenerative neural function disorders.
  • Early recognition and diagnosis are crucial for effective management.

Purpose of the Study:

  • To provide a basic introduction to neurometabolic diseases in neonates.
  • To assist primary care providers in recognizing signs and symptoms.
  • To guide the initiation of diagnostic sequences and facilitate interdisciplinary collaboration.

Main Methods:

  • Simplified presentation of metabolic pathways and concepts.
  • Focus on recognition, diagnostic sequencing, and specialist collaboration.
  • Educational material tailored for general newborn care practitioners.

Main Results:

  • Enhanced understanding of neurometabolic disease presentation in neonates.
  • Improved ability for primary care providers to identify potential cases.
  • Streamlined approach to initiating diagnostic workups.
  • Facilitation of effective communication between pediatricians, neurologists, geneticists, and metabolists.

Conclusions:

  • Early identification and diagnosis of neurometabolic diseases in neonates are critical.
  • This educational resource empowers primary care providers to manage these complex conditions.
  • Effective collaboration among specialists improves patient outcomes.

More Related Videos

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...